Literature DB >> 6439739

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.

J R Patsch, S Prasad, A M Gotto, G Bengtsson-Olivecrona.   

Abstract

In this study, we have investigated the effects of alimentary lipemia in 15 normotriglyceridemic individuals on high density lipoproteins2 (HDL2) with respect to structure, composition, and substrate efficacy for hepatic lipase in vitro. In the study subjects, HDL2 levels ranged widely from 4.7 to 151.7 mg/dl plasma. HDL2 were isolated in the postabsorptive (pa) state and in the postprandial (pp) state, i.e., 7 h after ingestion of a standard fatty meal. In going from the pa state to the pp state, HDL2 exhibited higher flotation rates and lower densities due to a decreased proportion of protein (38.7----36.2%) and a higher abundance in phospholipid (32.5----34.9%). There was a variable increase in triglyceride at the expense of cholesteryl esters; this increase was correlated positively with the magnitude of pp lipemia (r = 0.69, P less than 0.01) and inversely with HDL2 levels (r = -0.72, P less than 0.01). Hdl2 fractions were incubated with human hepatic lipase in vitro. Product lipoproteins formed from lipolysis of pa-HDL2 and triglyceride-poorer pp-HDL2 were reduced in phospholipid content (by 25 and 50%, respectively) but remained in the size and density range of native HDL2. By contrast, a major fraction of triglyceride-richer pp-HDL2 was converted to particles with density, size, and apoprotein composition of native HDL3. Changes consistent with these findings in vitro were observed in vivo also, where 15 h postprandially, individuals with high-level lipemia showed a decrease in HDL2 and rise in HDL3, while those with lower-level lipemia did not. This study indicates that the magnitude of postprandial lipemia determines the proportion of triglyceride in pp-HDL2, which in turn determines whether or not HDL2 are converted to HDL3 by hepatic lipase action.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439739      PMCID: PMC425390          DOI: 10.1172/JCI111624

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  In vitro exchanges of esterified cholesterol between serum lipoprotein fractions: studies of humans and rabbits.

Authors:  P J Barter; J I Lally
Journal:  Metabolism       Date:  1979-03       Impact factor: 8.694

2.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

3.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation.

Authors:  J R Patsch; S Sailer; G Kostner; F Sandhofer; A Holasek; H Braunsteiner
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

4.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

5.  Characterization of human high density lipoproteins by zonal ultracentrifugation.

Authors:  W Patsch; G Schonfeld; A M Gotto; J R Patsch
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

6.  Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase.

Authors:  K Shirai; R L Barnhart; R L Jackson
Journal:  Biochem Biophys Res Commun       Date:  1981-05-29       Impact factor: 3.575

7.  The hepatic heparin releasable lipase binds to high density lipoproteins.

Authors:  G Bengtsson; T Olivecrona
Journal:  FEBS Lett       Date:  1980-10-06       Impact factor: 4.124

8.  Stimulation of cholesterol ester exchange by lipoprotein-free rabbit plasma.

Authors:  D B Zilversmit; L B Hughes; J Balmer
Journal:  Biochim Biophys Acta       Date:  1975-12-17

9.  Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma.

Authors:  R E Morton; D B Zilversmit
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

10.  Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.

Authors:  T Kuusi; P Saarinen; E A Nikkilä
Journal:  Atherosclerosis       Date:  1980-08       Impact factor: 5.162

View more
  21 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Prescribing aerobic exercise for the regulation of postprandial lipid metabolism : current research and recommendations.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

3.  Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers.

Authors:  W Richmond; P W Seviour; T K Teal; R S Elkeles
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

4.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

5.  Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.

Authors:  M T Pedrini; M Kranebitter; A Niederwanger; S Kaser; J Engl; P Debbage; L A Huber; J R Patsch
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

6.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

8.  Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.

Authors:  B Föger; H Drexel; T Hopferwieser; G Miesenböck; A Ritsch; M Lechleitner; G Tröbinger; J R Patsch
Journal:  Clin Investig       Date:  1994-03

9.  Plasma activities of lecithin:cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo- or hyper-responsive to dietary cholesterol.

Authors:  G W Meijer; P N Demacker; A Van Tol; J E Groener; J G Van der Palen; A F Stalenhoef; L M Van Zutphen; A C Beynen
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

10.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

Authors:  G Miesenböck; B Hölzl; B Föger; E Brandstätter; B Paulweber; F Sandhofer; J R Patsch
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.